www.fastcompany.com
8 months agoPublic health
Moderna's vaccine helped fight COVID. Here's what's coming in its next wave of mRNA drugs
Moderna's pipeline of mRNA-based vaccine candidates could yield five new marketed products by 2026, according to a new analyst report from Oppenheimer.
Some of the experimental products in Moderna's pipeline include an influenza vaccine, a combination flu and COVID vaccine, an RSV vaccine, and an experimental cancer vaccine for melanoma. [ more ]